A multicenter Japanese study revealed that R1 resection, recurrent tumor, extremity location and CTNNB1 gene mutation status are adverse prognostic factors for postoperative local recurrence and preoperative drug treatment does not influence local recurrence [18]. This evidence concerns the gene CTNNB1 and neoplasm.